Literature DB >> 19911200

Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia.

Fiona Connell1, Kamini Kalidas, Pia Ostergaard, Glen Brice, Tessa Homfray, Lesley Roberts, David J Bunyan, Sally Mitton, Sahar Mansour, Peter Mortimer, Steve Jeffery.   

Abstract

Generalised lymphatic dysplasia (GLD) is characterised by extensive peripheral lymphoedema with visceral involvement. In some cases, it presents in utero with hydrops fetalis. Autosomal dominant and recessive inheritance has been reported. A large, non-consanguineous family with three affected siblings with generalised lymphatic dysplasia is presented. One child died aged 5 months, one spontaneously miscarried at 17 weeks gestation, and the third has survived with extensive lymphoedema. All three presented with hydrops fetalis. There are seven other siblings who are clinically unaffected. Linkage analysis produced two loci on chromosome 18, covering 22 Mb and containing 150 genes, one of which is CCBE1. A homozygous cysteine to serine change in CCBE1 has been identified in the proband, in a residue that is conserved across species. High density SNP analysis revealed homozygosity (a region of 900 kb) around the locus for CCBE1 in all three affected cases. This indicates a likely ancestral mutation that is common to both parents; an example of a homozygous mutation representing Identity by Descent (IBD) in this pedigree. Recent studies in zebrafish have shown this gene to be required for lymphangiogenesis and venous sprouting and are therefore supportive of our findings. In view of the conserved nature of the cysteine, the nature of the amino acid change, the occurrence of a homozygous region around the locus, the segregation within the family, and the evidence from zebrafish, we propose that this mutation is causative for the generalised lymphatic dysplasia in this family, and may be of relevance in cases of non-immune hydrops fetalis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911200     DOI: 10.1007/s00439-009-0766-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

Review 1.  Molecular lymphangiogenesis: new players.

Authors:  Tuomas Tammela; Tatiana V Petrova; Kari Alitalo
Journal:  Trends Cell Biol       Date:  2005-08       Impact factor: 20.808

2.  Expansion of the phenotype in Hennekam syndrome: a case with new manifestations.

Authors:  B Angle; J H Hersh
Journal:  Am J Med Genet       Date:  1997-08-08

3.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.

Authors:  A Irrthum; M J Karkkainen; K Devriendt; K Alitalo; M Vikkula
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

4.  Prox1 function is required for the development of the murine lymphatic system.

Authors:  J T Wigle; G Oliver
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

5.  Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.

Authors:  J Fang; S L Dagenais; R P Erickson; M F Arlt; M W Glynn; J L Gorski; L H Seaver; T W Glover
Journal:  Am J Hum Genet       Date:  2000-11-08       Impact factor: 11.025

6.  Candidate gene analysis in primary lymphedema.

Authors:  Robert E Ferrell; Mark A Kimak; Elizabeth C Lawrence; David N Finegold
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

Review 7.  Further delineation of Hennekam syndrome.

Authors:  L I Al-Gazali; J Hertecant; R Ahmed; N A Khan; R Padmanabhan
Journal:  Clin Dysmorphol       Date:  2003-10       Impact factor: 0.816

Review 8.  The pathophysiology of lymphedema.

Authors:  P S Mortimer
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

9.  Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation.

Authors:  R C Hennekam; R A Geerdink; B C Hamel; F A Hennekam; P Kraus; J A Rammeloo; A A Tillemans
Journal:  Am J Med Genet       Date:  1989-12

10.  Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24.

Authors:  G Brice; S Mansour; R Bell; J R O Collin; A H Child; A F Brady; M Sarfarazi; K G Burnand; S Jeffery; P Mortimer; V A Murday
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

View more
  36 in total

1.  GJC2 missense mutations cause human lymphedema.

Authors:  Robert E Ferrell; Catherine J Baty; Mark A Kimak; Jenny M Karlsson; Elizabeth C Lawrence; Marlise Franke-Snyder; Stephen D Meriney; Eleanor Feingold; David N Finegold
Journal:  Am J Hum Genet       Date:  2010-05-27       Impact factor: 11.025

2.  Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax.

Authors:  John D Kanady; Michael T Dellinger; Stephanie J Munger; Marlys H Witte; Alexander M Simon
Journal:  Dev Biol       Date:  2011-04-16       Impact factor: 3.582

Review 3.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

4.  A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression.

Authors:  Carolyn C Jackson; Lucy Best; Lazaro Lorenzo; Jean-Laurent Casanova; Jochen Wacker; Simone Bertz; Abbas Agaimy; Thomas Harrer
Journal:  J Clin Immunol       Date:  2015-12-19       Impact factor: 8.317

Review 5.  Vascular development in the zebrafish.

Authors:  Aniket V Gore; Kathryn Monzo; Young R Cha; Weijun Pan; Brant M Weinstein
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

6.  Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 Mutations.

Authors:  M Alders; A Mendola; L Adès; L Al Gazali; C Bellini; B Dallapiccola; P Edery; U Frank; F Hornshuh; S A Huisman; S Jagadeesh; H Kayserili; W T Keng; D Lev; C E Prada; J R Sampson; J Schmidtke; V Shashi; Y van Bever; N Van der Aa; J M Verhagen; J B Verheij; M Vikkula; R C Hennekam
Journal:  Mol Syndromol       Date:  2012-10-02

Review 7.  Development of the mammalian lymphatic vasculature.

Authors:  Ying Yang; Guillermo Oliver
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 8.  Lymphangiogenesis and hemangiogenesis: potential targets for therapy.

Authors:  Marlys H Witte; Michael T Dellinger; Donald M McDonald; S David Nathanson; Francesco M Boccardo; Corradino C C Campisi; Jonathan P Sleeman; Jeffrey E Gershenwald
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

9.  Mechanisms of Connexin-Related Lymphedema.

Authors:  Jorge A Castorena-Gonzalez; Scott D Zawieja; Min Li; R Sathish Srinivasan; Alexander M Simon; Cor de Wit; Roger de la Torre; Luis A Martinez-Lemus; Grant W Hennig; Michael J Davis
Journal:  Circ Res       Date:  2018-09-28       Impact factor: 17.367

10.  The secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesis.

Authors:  Zhiying Zou; David R Enis; Hung Bui; Eugene Khandros; Vinayak Kumar; Zoltan Jakus; Christopher Thom; Yiqing Yang; Veerpal Dhillon; Mei Chen; Minmin Lu; Mitchell J Weiss; Mark L Kahn
Journal:  Blood       Date:  2013-02-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.